MEDC - this gizmo is pretty expensive
350 mil and no products is a good starting point for a short. I see you are a careful investor, as I am. Yes, there is a bit of homework to do with these stocks, but you don't have to be a doctor.
MEDC is a very simple story. They have invented something real big, physicians are forced by law to use it, and the
market leader will pay heavy royalties to MEDC.
It's really stupid. Becton Dickinson is earning money on the stock, not on the product.
Here's an excerpt from the 10-Q as of 06/30/96 !!!
Business Overview
………
The Company designs and develops safety medical devices intended to reduce the incidence of accidental needlesticks. The Company has three core products under development: the Retractable Needle Hypodermic Syringe (the "Safety Syringe"), the Retractable Needle Vacuum Tube Phlebotomy Set (the "Safety Phlebotomy Set"), and the Retractable Needle Intravenous Catheter Insertion Device (the "Safety Catheter"). These products are similar in appearance and size to the standard devices in use. Such products incorporate the Company's novel proprietary retraction technology that enables a health care professional, with no substantial change in operating technique and using one hand, to permanently retract the needle of the device into the body of the device that can be safely discarded.
The Company also has several new products which are in the beginning stages of development. These new product developments include the In-Line Y-Port Injectable Access Needle, the Pre-filled Ampule Injector, the MDC Closed Injection System Injector, the Self-Contained Pre-Filled Syringe and the Pre-Filled Vial Injector (collectively the "New Products"). These products also incorporate the Company's proprietary retraction technology and are designed to reduce the incidence of accidental needlesticks. The Company has developed various sizes and designs of these products to accommodate the specific requirements of potential strategic allies for medical and dental applications. |
